Please login to the form below

Not currently logged in
Email:
Password:

Pfizer's Elvira Sanz named next president of Farmaindustria

Will lead Spanish pharma industry body for the new two years

Pfizer Spain Farmaindustria Elvira SanzSpanish pharmaceutical industry body Farmaindustria has selected Pfizer Spain's president and CEO Elvira Sanz to serve as its new president.

She will serve a two-year term and replaces Ferrer Grupo CEO Jordi Rementol, who took office in 2010.

Sanz has worked in the pharmaceutical industry for nearly 25 years, holding increasingly senior roles at Abelló, MSD, Roche and Cyanamid.

She became directorate general at Wyeth Spain in 2000 and was named president and CEO of Pfizer Spain in 2009.

Sanz takes up her new role at Farmaindustria at a time of increasing difficulties for the Spanish pharma industry, which has been hit hard by a series of government cost-containment measures and unpaid bills.

26th October 2012

From: Research, Sales, Marketing, Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health are expert navigators, helping healthcare clients uncover hidden insights, explore scientific options and make difficult strategic choices...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics